Axa
BLUE

Axa’s bluebird bio BLUE Stock Holding History

Axa’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-560
Closed -$34K – 1069
2023
Q3 		$34K Hold
560
– – ﹤0.01% 1053
2023
Q2 		$36.8K Sell
560
-665
-54% -$48.6K ﹤0.01% 1068
2023
Q1 		$77.9K Sell
1,225
-750
-38% -$85.7K ﹤0.01% 1084
2022
Q4 		$273K Buy
+1,975
New +$278K ﹤0.01% 1060
2021
Q1 		– Sell
-16,024
Closed -$8.98M – 1219
2020
Q4 		$8.98M Buy
16,024
+3,283
+26% +$2.08M 0.03% 549
2020
Q3 		$8.9M Buy
12,741
+2,423
+23% +$1.89M 0.03% 492
2020
Q2 		$8.16M Buy
+10,318
New +$7.78M 0.03% 484
2018
Q3 		– Sell
-1,598
Closed -$3.25M – 1334
2018
Q2 		$3.25M Sell
1,598
-371
-19% -$846K 0.01% 745
2018
Q1 		$4.35M Buy
1,969
+47
+2% +$120K 0.02% 690
2017
Q4 		$4.43M Buy
1,922
+1,073
+126% +$2.18M 0.02% 686
2017
Q3 		$1.51M Sell
849
-3,586
-81% -$5.01M 0.01% 866
2017
Q2 		$6.04M Sell
4,435
-5,127
-54% -$6.19M 0.03% 561
2017
Q1 		$11.3M Sell
9,562
-562
-6% -$573K 0.05% 386
2016
Q4 		$8.09M Sell
10,124
-2,510
-20% -$1.99M 0.04% 463
2016
Q3 		$11.1M Buy
12,634
+7
+0.1% +$5.07K 0.05% 370
2016
Q2 		$7.08M Buy
12,627
+1,136
+10% +$643K 0.03% 487
2016
Q1 		$6.33M Buy
11,491
+1,857
+19% +$1.14M 0.03% 495
2015
Q4 		$8.02M Sell
9,634
-690
-7% -$689K 0.04% 444
2015
Q3 		$11.4M Buy
10,324
+3,888
+60% +$7.09M 0.05% 351
2015
Q2 		$14M Hold
6,436
– – 0.06% 323
2015
Q1 		$10.1M Buy
6,436
+1,114
+21% +$1.47M 0.04% 407
2014
Q4 		$6.32M Buy
+5,322
New +$3.56M 0.03% 492

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Axa's BLUE Position: Q4 2023 in Review

Axa sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 560 shares — an estimated $34K sold.

Axa first reported a position in BLUE in Q4 2014 and held it in 22 quarters. The position peaked at $14M in Q2 2015. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Axa reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Axa sold 560 bluebird bio shares in Q4 2023, an estimated $34K.
  • Axa first reported a position in bluebird bio in Q4 2014 and held it in 22 quarters.
  • Axa's bluebird bio position peaked at $14M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Axa's 13F filing for Q4 2023, filed 14 Feb 2024.